Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehul Desai

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Annals of Indian Academy of Neurology|March 28, 2022
Editorial Commentary: Lipid Storage MyopathiesSatish Khadilkar, Mehul Desai
Journal of Thoracic Disease|October 30, 2018
Half-empty or half-full?-interpretation of the EOLIA trial and thoughts for the futureMehul Desai, Heidi J Dalton
Current Medical Research and Opinion|May 3, 2024
Evaluating unmet needs in large-volume subcutaneous drug delivery: U.S. payer perspectives on a novel, large-volume on-body delivery systemMehul Desai, James Kenney, Edmund Pezalla
The Journal of the Association of Physicians of India|June 24, 2023
Teleneurology for PhysiciansSatish Khadilkar, Mehul Desai, Darshan Pandya
PDA Journal of Pharmaceutical Science and Technology|August 23, 2024
Evaluating Unmet Needs in Large-Volume Subcutaneous Drug Delivery: US Payer Perspectives on a Novel, Large-Volume On-Body Delivery SystemMehul Desai, James Kenney, Edmund Pezalla
The AAPS Journal|April 6, 2006
Blood pressure as an example of a biomarker that functions as a surrogateMehul Desai, Norman Stockbridge, Robert Temple
Diabetes Care|July 24, 2015
Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical ProgramNgozi Erondu, Mehul Desai, Kirk Ways, et al.
Diabetes Care|December 24, 2015
Response to Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686Ngozi Erondu, Mehul Desai, Kirk Ways, et al.
Current Medical Research and Opinion|April 6, 2016
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitusMaria Alba, John Xie, Albert Fung, et al.
Statistics in Medicine|August 19, 2004
QT analysis: a complex answer to a 'simple' problemLang Li, Mehul Desai, Zeruesenay Desta, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Annals of Indian Academy of Neurology|March 28, 2022
Editorial Commentary: Lipid Storage MyopathiesSatish Khadilkar, Mehul Desai
Journal of Thoracic Disease|October 30, 2018
Half-empty or half-full?-interpretation of the EOLIA trial and thoughts for the futureMehul Desai, Heidi J Dalton
Current Medical Research and Opinion|May 3, 2024
Evaluating unmet needs in large-volume subcutaneous drug delivery: U.S. payer perspectives on a novel, large-volume on-body delivery systemMehul Desai, James Kenney, Edmund Pezalla
The Journal of the Association of Physicians of India|June 24, 2023
Teleneurology for PhysiciansSatish Khadilkar, Mehul Desai, Darshan Pandya
PDA Journal of Pharmaceutical Science and Technology|August 23, 2024
Evaluating Unmet Needs in Large-Volume Subcutaneous Drug Delivery: US Payer Perspectives on a Novel, Large-Volume On-Body Delivery SystemMehul Desai, James Kenney, Edmund Pezalla
The AAPS Journal|April 6, 2006
Blood pressure as an example of a biomarker that functions as a surrogateMehul Desai, Norman Stockbridge, Robert Temple
Diabetes Care|July 24, 2015
Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical ProgramNgozi Erondu, Mehul Desai, Kirk Ways, et al.
Diabetes Care|December 24, 2015
Response to Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686Ngozi Erondu, Mehul Desai, Kirk Ways, et al.
Current Medical Research and Opinion|April 6, 2016
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitusMaria Alba, John Xie, Albert Fung, et al.
Statistics in Medicine|August 19, 2004
QT analysis: a complex answer to a 'simple' problemLang Li, Mehul Desai, Zeruesenay Desta, et al.
Pageof 9